Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach dose of Mounjaro is 0.5 ml, regardless of which strength you are using. Whether your pen contains 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg, the injected volume stays the same at 0.5 ml — the dose is controlled by the concentration of tirzepatide in the solution, not by how much liquid is delivered. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber decides which strength is right for you based on a full clinical assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Imagine you've just received your first Mounjaro KwikPen. Before you inject, you might peer at it and think: how much liquid is actually going in? The answer is 0.5 ml, roughly ten drops of water, or about a tenth of a standard teaspoon. It is a very small volume, which surprises many people expecting something more substantial. That small amount is quite deliberate: subcutaneous injections work best when they deliver a compact bolus of liquid into the tissue just beneath the skin, and 0.5 ml sits comfortably within that range.
Because every strength uses the same 0.5 ml volume, the full pen holds 2 ml total, four doses of 0.5 ml each, delivered once a week over a four-week period. If you have ever wondered how many doses are in one Mounjaro pen, that is the answer: four. The pen is designed so that each press of the button delivers one pre-measured 0.5 ml dose and then locks the mechanism, making it impossible to accidentally take more.
One point worth being clear about: the volume does not change as you move up through the strengths. If you are curious about how many ml make up a single Mounjaro dose, the answer is the same at every stage of treatment, 0.5 ml, whether you are on 2.5 mg or 15 mg. What changes is the concentration of tirzepatide dissolved in that liquid. This is standard pharmaceutical practice and means the injection experience feels similar at every stage of your treatment.
A question our prescribers hear most weeks is whether a higher-strength pen feels different to inject or delivers more liquid. It does not. Eli Lilly formulated Mounjaro so that every strength fits the same 0.5 ml delivery window. The 2.5 mg pen contains a lower concentration of tirzepatide per millilitre; the 15 mg pen contains a much higher one. The syringe mechanism, the needle, and the injected volume are identical across all six strengths available in the UK: 2.5, 5, 7.5, 10, 12.5, and 15 mg.
This matters practically for a few reasons. First, you do not need to adjust your injection technique as your dose increases, the process is the same every time. Second, if you are ever checking the cartridge window and notice the liquid level after each dose, you should see it drop by roughly the same amount each week regardless of strength. Third, it means that injection-site comfort, which depends partly on volume, does not worsen as treatment progresses. For a full breakdown of the specific 5 mg pen and its concentration, the volume details for Mounjaro 5 mg are covered separately.
The clinical reasoning behind how the dose schedule is structured (starting at 2.5 mg and titrating upwards) is covered on the Mounjaro overview page. The short version: treatment begins at the lowest strength to allow the body to adjust gradually, with the prescriber reviewing progress before any increase is considered. That clinical process sits entirely outside what the pen's volume tells you.
Some people count the clicks they hear when injecting and wonder whether the number of clicks relates to the volume. It does not, directly. The click sound you hear at the start and end of the injection is a mechanism indicator, not a volume counter. If you want to understand how many clicks one dose of Mounjaro makes, that page covers the KwikPen's mechanism in detail. For volume purposes, the answer remains 0.5 ml per dose whatever you hear.
The SmPC and Patient Information Leaflet for Mounjaro, available via the eMC (electronic Medicines Compendium), confirm the 0.5 ml per dose figure and are the authoritative reference for all technical details about the pen. The NHS tirzepatide medicine information page at nhs.uk/medicines/tirzepatide also provides patient-facing guidance on how to use the pen correctly.
One practical note on storage: the liquid in the cartridge should be clear and colourless. If it looks cloudy, discoloured or contains particles, do not use it. The pen should be stored in the fridge between 2°C and 8°C. For the exact room-temperature window (how long a pen can be kept outside the fridge before the dose is no longer useable) always check the leaflet that comes with your pen rather than relying on any secondary source, including this page. That window is stated precisely in the Patient Information Leaflet and is the figure your prescriber and pharmacist will refer to.
If you missed a dose or are unsure what to do after a delayed injection, guidance on a Mounjaro dose missed by two days explains the practical steps. For anything specific to your treatment plan, your prescriber is always the right person to ask. Mounjaro is a prescription-only medicine, and adjustments to timing, strength or technique should only happen following clinical review.
If you are still working out whether Mounjaro might be suitable for you, the free consultation at nume is the place to start. A GPhC-registered prescriber reviews every application personally, the same day it is submitted.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.